CEUAX | PRITX | CEUAX / PRITX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 45 years | - |
Gain YTD | 6.267 | 5.964 | 105% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 131B | 13.6B | 963% |
Annual Yield % from dividends | 1.50 | 1.06 | 142% |
Returns for 1 year | 8.44 | 8.35 | 101% |
Returns for 3 years | -4.16 | 5.91 | -70% |
Returns for 5 years | 9.53 | 12.26 | 78% |
Returns for 10 years | 35.28 | 39.96 | 88% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SCHQ | 32.47 | 0.06 | +0.19% |
Schwab Long-Term US Treasury ETF | |||
TLH | 102.08 | 0.05 | +0.05% |
iShares 10-20 Year Treasury Bond ETF | |||
HELX | 30.33 | -0.04 | -0.14% |
Franklin Genomic Advancements ETF | |||
FKU | 38.97 | -0.40 | -1.02% |
First Trust United Kingdom AlphaDEX® ETF | |||
THD | 60.60 | -1.60 | -2.58% |
iShares MSCI Thailand ETF |